Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for HCW Biologics Inc. (HCWB : NSDQ)

• Company Description    HCW Biologics Inc. is a preclinical stage biopharmaceutical company. It focused on discovering and developing novel immunotherapies. HCW Biologics Inc. is based in MIRAMAR, Fla. Number of Employees: 35

• Price / Volume Information    Yesterday's Closing Price: $2.50 Daily Weekly Monthly 20 Day Moving Average: 61,441 shares Shares Outstanding: 1.60 (millions) Market Capitalization: $3.99 (millions) Beta: 2.29 52 Week High: $44.10 52 Week Low: $1.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -62.79% -63.06% 12 Week -11.56% -13.98% Year To Date -57.06% -54.29%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2929 N COMMERCE PKWY - MIRAMAR,FL 33025 USA ph: 954-842-2024 fax: 954-842-2037 mmcenroe@tiberend.com http://www.hcwbiologics.com

• General Corporate Information    Officers Hing C. Wong - Founder; Chief Executive Officer Scott T. Garrett - Chairperson of the Board of Directors Rebecca Byam - Chief Financial Officer Lisa M. Giles - Director Rick S. Greene - Director Peer Information HCW Biologics Inc. (CORR.) HCW Biologics Inc. (RSPI) HCW Biologics Inc. (CGXP) HCW Biologics Inc. (BGEN) HCW Biologics Inc. (GTBP) HCW Biologics Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 40423R303 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/17/26 Share - Related Items Shares Outstanding: 1.60 Most Recent Split Date: 6.00 (0.17:1) Beta: 2.29 Market Capitalization: $3.99 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/17/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.49 Price/Cash Flow: - Price / Sales: 0.61 EPS Growth vs. Year Ago Period: 840.01% vs. Previous Quarter: 114.07% Sales Growth vs. Year Ago Period: 130,760.01% vs. Previous Quarter: 24,133.33% ROE 06/30/26 - - 03/31/26 - -486.87 12/31/25 - - ROA 06/30/26 - - 03/31/26 - -29.19 12/31/25 - -51.05 Current Ratio 06/30/26 - - 03/31/26 - 0.09 12/31/25 - 0.11 Quick Ratio 06/30/26 - - 03/31/26 - 0.09 12/31/25 - 0.11 Operating Margin 06/30/26 - - 03/31/26 - -117.56 12/31/25 - -24,401.82 Net Margin 06/30/26 - - 03/31/26 - -34.73 12/31/25 - -14,472.73 Pre-Tax Margin 06/30/26 - - 03/31/26 - -29.73 12/31/25 - -14,677.68 Book Value 06/30/26 - - 03/31/26 - 5.13 12/31/25 - 5.06 Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Equity 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©